MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Castlight Health Company Profile (NASDAQ:CSLT)

Consensus Ratings for Castlight Health (NASDAQ:CSLT) (?)
Ratings Breakdown: 4 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $7.71 (148.05% upside)

Analysts' Ratings History for Castlight Health (NASDAQ:CSLT)
Show:
DateFirmActionRatingPrice TargetActions
12/16/2015Topeka Capital MarketsInitiated CoverageBuy$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2015FBR & Co.Initiated CoverageMarket Perform$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2015Canaccord GenuityReiterated RatingHold$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2015Stifel NicolausBoost Price TargetBuy$7.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2015Leerink SwannDowngradeOutperform -> Market Perform$14.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2015First AnalysisUpgradeEqual Weight -> Overweight$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015Canaccord GenuityReiterated RatingHold$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2015Canaccord GenuityBoost Price TargetHold$9.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2015Raymond JamesReiterated RatingOutperform$10.00 -> $12.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Canaccord GenuityLower Price TargetHold$10.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2015Wells FargoInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Canaccord GenuityDowngradeBuy -> Hold$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Stifel NicolausLower Price TargetBuy$17.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/5/2014First AnalysisInitiated CoverageEqual WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2014Leerink SwannInitiated CoverageOutperform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2014Raymond JamesReiterated RatingOutperform$15.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2014Raymond JamesReiterated RatingOutperform$26.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2014Stifel NicolausSet Price TargetBuy$24.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2014Canaccord GenuityLower Price Target$25.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2014Raymond JamesInitiated CoverageOutperform$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2014Canaccord GenuityInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2014Goldman SachsInitiated CoverageNeutral -> Neutral$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2014Stifel NicolausInitiated CoverageBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2014Morgan StanleyInitiated CoverageEqual WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/9/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha